Texas A&M announces start of production on two COVID-19 vaccine candidates.
Production begins in Texas on two different COVID-19 vaccine candidates
News Staff
FUJIFILM Diosynth Biotechnologies, and the Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM) Jan. 11 announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S.
Monday, January 11, 2021
